MLchartDataset catalogue

Folitixorin

Term · Oncology and biomedicine · MLC-T-ONC-013748

A folate-based biomodulator with potential antineoplastic activity. Folitixorin stabilizes the covalent binding of the fluorouracil metabolite 5-5-fluoro-2'-deoxyuridine-5'-O-monophosphate (FdUMP) to its target enzyme, thymidylate synthase, which results in inhibition of thymidylate synthase, depletion of thymidine triphosphate (TTP), a necessary constituent of DNA, and tumor cell death. Unlike leucovorin, folitixorin, as the active form of folate, does not require metabolic activation and may increase the chemotherapeutic effects of fluorouracil with lower toxicity.

Table 1. Record
IdentifierMLC-T-ONC-013748
FieldOncology and biomedicine
Abbreviation5,10-MTHF
Synonyms5,10 methylenetetrahydrofolate; 5,10-methylenetetrahydrofolate
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-013748",
  "term": "Folitixorin",
  "field": "Oncology and biomedicine",
  "definition": "A folate-based biomodulator with potential antineoplastic activity. Folitixorin stabilizes the covalent binding of the fluorouracil metabolite 5-5-fluoro-2'-deoxyuridine-5'-O-monophosphate (FdUMP) to its target enzyme, thymidylate synthase, which results in inhibition of thymidylate synthase, depletion of thymidine triphosphate (TTP), a necessary constituent of DNA, and tumor cell death. Unlike leucovorin, folitixorin, as the active form of folate, does not require metabolic activation and may increase the chemotherapeutic effects of fluorouracil with lower toxicity.",
  "abbreviation": "5,10-MTHF",
  "synonyms": [
    "5,10 methylenetetrahydrofolate",
    "5,10-methylenetetrahydrofolate"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/folitixorin/"
}

Record 7,542 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.